Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO 542 in HIV-infected patients
NCT00055185Phase 2Completed
- Sponsor
- Progenics Pharmaceuticals
- Start
- Apr 2003
- Countries
- 1
01
Overview
A Phase 2 trial of CD4-IgG2 in human immunodeficiency virus infection (HIV), sponsored by Progenics Pharmaceuticals. Started Apr 2003; status: completed.
02
Drugs
CD4-IgG2
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00055185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00055185.